Arbutus Biopharma Corp
ABUS
Market Cap$599.48M
Close$
$-0.44
113.4% downside
Current Fair Value
113.4% downsideOvervalued by 113.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $599.48 Million |
|---|---|
| Enterprise Value | $570.35 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.38 |
| Beta | 1.24 |
| Outstanding Shares | 190,707,085 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.8 |
|---|---|
| PEG | -20.95 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 89.08 |
| Enterprise Value to EBIT | -7.15 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Arbutus Biopharma Corp
CEO: William Collier